SEC Insider Transactions from Cobb Stuart.

Last updated: 2026-03-17 23:01 UTC | Total transactions: 9

Cobb Stuart, Chief Scientific Officer of Neurogene Inc. ($NGNE), sold shares once on the open market in the last 365 days for a total of $103 thousand. His most recent sale occurred on May 14, 2025. These sales rank 9,532nd among 11,678 insiders in our database, where the average is $8.6 million across about 6.4 transactions. Stuart made no open market purchases during this period.

Set Up your own filters →
Transaction Date Company Ticker Insider Name Title Transaction Type Security Shares Price Shares Owned Following Total Shares Outstanding % of Owned % of Outstanding
March 13, 2026 Neurogene Inc. $NGNE Cobb Stuart Chief Scientific Officer S Common Stock 3991 $20.41 33,303.0000 21,168,431 10.70% 0.02%
March 13, 2026 Neurogene Inc. $NGNE Cobb Stuart Chief Scientific Officer S Common Stock 148 $22.08 30,497.0000 21,168,431 0.48% 0.00%
March 13, 2026 Neurogene Inc. $NGNE Cobb Stuart Chief Scientific Officer S Common Stock 2658 $21.34 30,645.0000 21,168,431 7.98% 0.01%
Feb. 20, 2026 Neurogene Inc. $NGNE Cobb Stuart Chief Scientific Officer A Common Stock 16500 $0.00 37,294.0000 21,168,431 79.35% 0.08%
May 14, 2025 Neurogene Inc. $NGNE Cobb Stuart Chief Scientific Officer S Common Stock 6797 $15.15 20,794.0000 17,567,082 24.63% 0.04%
March 26, 2025 Neurogene Inc. $NGNE Cobb Stuart Chief Scientific Officer A Employee Stock Option (Right to buy) 42900 $0.00 42,900.0000 17,567,082 9999.99% 0.24%
March 26, 2025 Neurogene Inc. $NGNE Cobb Stuart Chief Scientific Officer A Common Stock 7200 $0.00 27,591.0000 17,567,082 35.31% 0.04%
March 13, 2024 Neurogene Inc. $NGNE Cobb Stuart Chief Scientific Officer A Stock Option (Right to Buy) 34450 $0.00 34,450.0000 4,656,947 9999.99% 0.74%
March 13, 2024 Neurogene Inc. $NGNE Cobb Stuart Chief Scientific Officer A Common Stock 20391 $0.00 20,391.0000 4,656,947 9999.99% 0.44%